In un’intervista a Time,...
Nothing adds up in Israel’s narrative about the FlyDubai “hijacking”—and CNN just accidentally exposed the truth. Israeli Prime Minister Benjamin Netanyahu has been selling the FlyDubai incident as pure Hollywood heroism: a co-pilot turns terrorist, [...]
The post CNN Accidentally Exposes Israeli ‘FlyDubai’ False Flag Operation: ‘Hollywood Production’ appeared first on The People's Voice.
Ghana has rejected a proposed health compact with the United States that would have provided an estimated $109 million in US health funding over five years, with President John Dramani Mahama saying the agreement raised serious concerns over health data, financing obligations, and Ghana’s regulatory authority.
The decision places Ghana among a few African countries that have pushed back against new US health agreements introduced as Washington restructures its foreign assistance following the dismantling of USAID. Zimbabwe has also rejected a similar agreement, while Zambia has raised concerns over provisions in its negotiations with the United States.
Speaking at the Council on Foreign Relations in New York on September 25, Mahama said the proposed compact was presented to Ghana as a replacement for health funding previously provided through USAID.
He said Ghana’s Ministry of Health reviewed the document before preparing a Cabinet Information Paper.
“Ghana is a sovereign nation, and we have our own processes. We are a democratic country,” Mahama said.
According to the President, the Cabinet identified several provisions that raised concerns, particularly those relating to Ghana’s health information.
“One, it says that we shall give the United States our pathogen profile,” he said, adding that the agreement also required Ghana to provide medical records.
“It also says we should give our medical records. I mean, who takes another country’s medical records? And so that was strange.”
Concerns over health-data sharing have been central to resistance to the new US health agreements in several African countries.
Mahama also raised concerns about the treatment of medicines and other medical products supplied under the proposed arrangement.
He said Ghana would have been required to contribute funding to the program while, according to his account of the compact, the country’s Food and Drugs Authority would not have been able to inspect medicines or other medical products entering Ghana under the program.
“And then it also says that any medications or any medical products that shall be brought into our country, our Food and Drugs Administration has absolutely no right to inspect,” Mahama said.
“I mean, it was humiliating.”
Ghanaian officials had previously cited concerns about the proposed handling of sensitive health information as a reason for rejecting the agreement. Reporting on the negotiations also indicated that the proposed arrangement would have required additional investment from Ghana alongside the US contribution.
Mahama said the proposal was rejected after the Health Ministry presented its assessment to the Cabinet.
He described the decision as unusually swift.
“It was the compact that was thrown out in record time in our Cabinet. I’ve never seen anything thrown out as fast as that.”
He said the government subsequently instructed the Health Minister to communicate Ghana’s position to the US ambassador.
“And so, of course, we rejected it. And we asked the health minister to inform the US ambassador that we didn’t need it. We’ll manage ourselves.”
The proposed agreement would have provided Ghana with about $109 million in US health assistance over five years. The negotiations had begun in late 2025.
Ghana’s decision comes as the United States seeks to shift its approach to global health cooperation. The new US strategy places greater emphasis on recipient countries taking responsibility for financing and delivering health programs, while Washington reduces its traditional aid commitments.
Kenya became the first African country to sign the agreement which was challenged in court, followed by similar arrangements with Rwanda, Liberia, Uganda, Lesotho and Eswatini, among other countries. Ravi Ram from the People’s Health Movement (PHM) East and South Africa, told BreakThrough News in December 2025, that “Bilateral agreements between the US and Kenya and other African countries are meant to limit the ability of any one ‘partner’ country to challenge the terms of implementing the agreement, due to the unequal power relations.”
The concerns among health activists and concerned Africans is the ability of African states to determine their own health priorities, regulate medicines, control sensitive health information, and collectively negotiate the terms of international health cooperation.
AI agents don’t go rogue. That’s something only humans do. Nevertheless, a New York Times article – representative of much news coverage of AI – described an OpenAI hacking as “A.I. bots going rogue and independently spearheading a cyberattack.” Name-brand artificial intelligence agents have been on a hacking spree in 2026. OpenAI’s software agents hacked […]
The post Computer science has long understood how to keep AI under control appeared first on Asia Times.
I’m now convinced that the president lives on an entirely different plane of reality from you and me.
© Kevin Dietsch
by Nicolas Hulscher, MPH – originally published on Focal Points substack
VERSIONE SINTETICA IN ITALIANO
All links to previous Gospa News posts have been added in the aftermath by virtue of the ties with topics covered
Florida Attorney General James Uthmeier has filed a sweeping lawsuit against Pfizer and its CEO, Albert Bourla, accusing them of deceiving the public about the safety and transmission-prevention capabilities of Pfizer’s COVID-19 mRNA injection.
The 49-page complaint was filed on October 1, 2026, in St. Lucie County, Florida, and targets Pfizer and Bourla personally under Florida’s Deceptive and Unfair Trade Practices Act.
The complaint opens with a striking line: “Those people are criminals.”That is how Bourla described people who publicly raised safety concerns about Pfizer’s COVID-19 injection.
At the center of the case is an explosive allegation: Pfizer publicly assured Americans that its COVID shot was safe while the company possessed internal and external safety information involving myocarditis, miscarriages, strokes, adverse events, and deaths.
According to the complaint, Pfizer’s own adverse-event database contained 158,893 adverse events from 42,086 case reports by February 28, 2021—only about 10 weeks after the vaccine received emergency authorization.
Yet in January 2023, Bourla publicly stated that Pfizer had seen “not a single [safety] signal” despite billions of doses having been administered.
Florida argues that statement was fundamentally incompatible with information already known about myocarditis and pericarditis.
The complaint also states that Pfizer’s database contained 1,223 reported fatalities following vaccination as of February 28, 2021.
Florida argues that the existence of this volume of serious adverse-event information undermined Pfizer’s sweeping public safety messaging.
The volume of reports became so large, according to the filing, that Pfizer hired 600 additional full-time employees and expected to hire another 1,800 workers to process adverse-event reports.
Another major section of the lawsuit concerns pregnancy.
The complaint states that by February 28, 2021, Pfizer had reports involving 458 pregnant women exposed to its COVID vaccine. Of those reports, 248 involved an adverse event and 52 involved miscarriage, according to the filing. Nearly all of the reported miscarriages occurred during the first trimester.
The lawsuit also points to Pfizer’s planned clinical trial involving pregnant women.
Pfizer initially sought approximately 4,000 participants, but the complaint states that only 348 mothers and 335 infants were ultimately enrolled and that the study was terminated early. The women vaccinated in that study were 24–34 weeks pregnant, meaning the trial did not directly provide first-trimester vaccination data.
The complaint further cites the Comirnaty package insert as stating that there are no available data on use before 24 weeks sufficient to inform risks for major birth defects and miscarriage.
The second enormous pillar of Florida’s case concerns transmission. Pfizer and Bourla repeatedly told the public that vaccination would protect other people.
In December 2021, for example, Pfizer said that getting as many people vaccinated and boosted as possible remained the best course of action to “prevent the spread of COVID-19.”
But according to the complaint, Pfizer’s pivotal clinical trial did not test whether vaccination prevented person-to-person transmission.
The FDA itself stated in December 2020 that there was no evidence at that time that the vaccine prevented SARS-CoV-2 transmission from one person to another, and transmission was not an objective of Pfizer’s trial protocol.
A Pfizer executive later publicly acknowledged that the vaccine had not been tested for stopping transmission before entering the market.
Florida alleges that Pfizer nevertheless used the idea of protecting loved ones as a powerful marketing tool to increase vaccine uptake.
The financial stakes were enormous. The complaint states that Pfizer turned approximately $1.5 billion in research and development spending into more than $80 billion in COVID vaccine revenue.
Pfizer’s vaccine captured nearly 70% of the U.S. and European COVID vaccine markets, according to figures cited in the complaint.
Meanwhile, Bourla received approximately $101.8 million in compensation from Pfizer between 2020 and 2023.
Florida’s complaint goes beyond safety claims and accuses Pfizer of engaging in broader unfair business practices to dominate the COVID vaccine market.
Florida is seeking far more than a symbolic judgment. The Attorney General is asking the court for civil penalties, a permanent injunction against deceptive or unfair representations concerning Pfizer’s COVID vaccine, attorneys’ fees and other relief.
Most significantly, Florida is also seeking disgorgement—legal language meaning Pfizer could be forced to hand back profits connected to conduct the court ultimately determines violated Florida law.
Finally, a government is attempting to hold Pfizer and Albert Bourla accountable by at least some degree for their gross deception.
For years, the company’s false safety and transmission claims helped drive mass vaccine uptake. Now those fraudulent claims are headed to court.
Epidemiologist and Foundation Administrator, McCullough Foundation
Support our mission: mcculloughfnd.org
Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.
MAIN SOURCE
Attorney General James Uthmeier Files Lawsuit Against Pfizer and its CEO Dr. Albert Bourla
Login